Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTime Finance Regulatory News (TIME)

Share Price Information for Time Finance (TIME)

Share Price is delayed by 15 minutes
Get Live Data
48.00    1.50 (3.23%)
Bid:
47.00
Ask:
49.00
Spread: 2.00 (4.255%)
Market Cap: £44.01m
TIME Live PriceLast checked at - London Stock Exchange

Intraday Time Finance Share Chart

Rule 8.1- (Timestrip)

24 Mar 2010 09:50

RNS Number : 0900J
J.M. Finn & Co
24 March 2010
 



FORM 8.1

DEALINGS BY OFFERORS, OFFEREE COMPANIES OR THEIR ASSOCIATES

FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS

(Rules 8.1(a) and (b)(i) of the Takeover Code)

 

1. KEY INFORMATION

 

Name of person dealing (Note 1)

J. M. FINN & CO LIMITED

Company dealt in

TIMESTRIP

Class of relevant security to which the dealings being disclosed relate (Note 2)

ORD GBP0.002

Date of dealing

23rd March 2010

 

 

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

 

 

Long

Short

 

 

Number (%)

Number (%)

(1) Relevant securities

 

70,000 0.01%

(2) Derivatives (other than options)

 

(3) Options and agreements to purchase/sell

 

Total

 

70,000 0.01%

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 

Class of relevant security:

 

Long

Short

 

 

Number (%)

Number (%)

(1) Relevant securities

 

(2) Derivatives (other than options)

 

(3) Options and agreements to purchase/sell

 

Total

 

 

(c) Rights to subscribe (Note 3)

 

Class of relevant security:

 

Details

 

 

 

3. DEALINGS (Note 4)

 

(a) Purchases and sales

 

Purchase/sale

 

Number of securities

Price per unit (Note 5)

SALE

20,000

 

0.4p

 

 

 

(b) Derivatives transactions (other than options)

 

Product name,

e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

 

 

 

 

 

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

 

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise

price

Type, e.g. American, European etc.

Expiry

date

Option money

paid/received per unit (Note 5)

 

 

(ii) Exercising

 

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including new securities) (Note 4)

 

Nature of transaction (Note 8)

 

Details

Price per unit (if applicable) (Note 5)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9) YES/NO

 

 

Date of disclosure

24th March 2010

Contact name

Mitesh Patel

Telephone number

0203 207 3325

Name of offeree/offeror with which associated

TIMESTRIP

Specify category and nature of associate status (Note 10)

CONNECTED ADVISOR

 

 

Notes

 

The Notes on Form 8.1 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DCCKZLBLBXFZBBD
Date   Source Headline
23rd Apr 20077:02 amRNSStrategic Partnership
2nd Apr 20075:27 pmRNSTotal Voting Rights
2nd Apr 20075:22 pmRNSAdditional Listing
8th Mar 20077:04 amRNSPackaging Partnership
7th Mar 20073:32 pmRNSDirectorate Change
7th Mar 20073:28 pmRNSAdditional Listing
5th Mar 20077:00 amRNSPatent Update
28th Feb 20075:22 pmRNSTotal Voting Rights
19th Feb 20077:01 amRNSAppointment of Distributor
15th Feb 20074:36 pmRNSAdditional Listing
12th Feb 20077:01 amRNSNew Strategic Partnership
8th Feb 20077:02 amRNSiStrip Progress
5th Feb 20074:55 pmRNSAdditional Listing
2nd Feb 20077:00 amRNSStrategic Partnership
2nd Feb 20077:00 amRNSTrading Statement
15th Jan 20076:17 pmRNSAdditional Listing
28th Dec 20067:00 amRNSTotal Voting Rights
19th Dec 20065:57 pmRNSAdditional Listing
20th Oct 20065:30 pmRNSAdditional Listing
18th Sep 20068:46 amRNSNew Technology
18th Sep 20068:45 amRNSInterim Results
4th Sep 20062:55 pmRNSAdditional Listing
25th Jul 20062:58 pmRNSAdditional Listing
29th Jun 200610:18 amRNSResult of AGM
12th Jun 20063:46 pmRNSAnnual Report and Accounts
5th Jun 200612:11 pmRNSAdditional Listing
31st May 200612:29 pmRNSAdditional Listing
16th May 20062:59 pmRNSAdditional Listing
11th May 20067:01 amRNSFinal Results
9th May 20063:16 pmRNSAdditional Listing
5th May 20067:00 amRNSNestle adopts technology
28th Mar 200610:31 amRNSNotice of Exercise of Warrant
28th Mar 200610:24 amRNSAdditional Listing
28th Mar 200610:21 amRNSAdditional Listing
10th Mar 20062:12 pmRNSAdditional Listing
13th Feb 20068:00 amRNSChange of Adviser
10th Feb 20065:35 pmPRNShareholding
9th Feb 20067:00 amPRNTechnology Breakthrough
3rd Feb 20067:00 amPRNEuropean Contract Win
10th Jan 200610:00 amPRNHolding(s) in Company
6th Dec 20054:00 pmPRNExercise of Warrants and Convertible Loan Stock
18th Nov 20057:00 amPRNTrading Update
9th Nov 20052:59 pmPRNSignificant Shareholdings
1st Nov 200510:08 amPRNIssue of New Shares
11th Oct 20056:00 amPRNPlacing
28th Sep 20059:28 amPRNSignificant Shareholding
23rd Sep 20056:00 amPRNInterim Results
16th Aug 20054:03 pmPRNChange of Adviser
30th Jun 20051:55 pmPRNFinal Results
18th Apr 20056:00 amPRNLaunch with Crown

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.